“…Within the last years artificial blood substitutes have gained more and more attention because of the above mentioned decrease of available RBCs (Ruchalla 2013, Njoku et al 2015, Chung et al 2016, Ellingson et al 2017, Taguchi et al 2017, Ferenz and Steinbicker 2019. Since the application of a pure solution of haemoglobin is impractical due to the enormous nephrotoxicity and short circulation time (Chang 2006), several different attempts have been made to create biocompatible artificial oxygen carriers, based on either perfluorocarbons or haemoglobin that needs to be encapsulated in protective shells in any case (Bauer et al 2010, von Storp et al 2012, Ferenz et al 2013, Sakai et al 2013, Stephan et al 2014, Wrobeln, Laudien, et al 2017, Wrobeln, Schlüter, et al 2017.…”